Condition
End Stage Lung Disease
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Terminated1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07516379Recruiting
GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation
NCT05289570Phase 2Terminated
Voxelotor for Improving Oxygen Saturation in Adults
NCT06428513Not ApplicableUnknown
Health Coaching Telemedicine Program for Lung Transplant Candidates With End-stage Lung Disease.
NCT04351945Unknown
Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
Showing all 4 trials